Perceptive Advisors LLC Rhythm Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

  • $2.28 Billion
  • Q2 2025

A detailed history of Perceptive Advisors LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 2,418,299 shares of RYTM stock, worth $239 Million. This represents 6.71% of its overall portfolio holdings.

Number of Shares
2,418,299
Previous 2,548,445 5.11%
Holding current value
$239 Million
Previous $135 Million 13.2%
% of portfolio
6.71%
Previous 5.65%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$46.95 - $68.11 $6.11 Million - $8.86 Million
-130,146 Reduced 5.11%
2,418,299 $153 Million
Q1 2025

May 15, 2025
SELL
$48.56 - $61.02 $55 Million - $69.1 Million
-1,132,028 Reduced 30.76%
2,548,445 $135 Million
Q4 2024

Feb 14, 2025
BUY
$46.91 - $67.33 $5.64 Million - $8.1 Million
120,259 Added 3.38%
3,680,473 $206 Million
Q3 2024

Nov 14, 2024
BUY
$40.81 - $55.0 $4.64 Million - $6.25 Million
113,635 Added 3.3%
3,560,214 $187 Million
Q2 2024

Aug 14, 2024
BUY
$35.41 - $44.37 $6.3 Million - $7.9 Million
178,000 Added 5.45%
3,446,579 $142 Million
Q1 2024

May 15, 2024
BUY
$39.12 - $52.44 $43.6 Million - $58.4 Million
1,114,469 Added 51.74%
3,268,579 $142 Million
Q4 2023

Feb 14, 2024
BUY
$21.39 - $49.64 $37.9 Million - $88 Million
1,773,282 Added 465.64%
2,154,110 $99 Million
Q3 2023

Nov 14, 2023
BUY
$15.81 - $27.8 $6.02 Million - $10.6 Million
380,828 New
380,828 $8.73 Million
Q2 2020

Aug 14, 2020
SELL
$14.41 - $25.35 $2.46 Million - $4.33 Million
-170,859 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.53 - $25.5 $3.34 Million - $4.36 Million
170,859 New
170,859 $3.92 Million
Q3 2019

Nov 14, 2019
SELL
$18.62 - $24.51 $4.9 Million - $6.45 Million
-262,970 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$21.11 - $28.48 $5.07 Million - $6.84 Million
-240,000 Reduced 47.72%
262,970 $5.79 Million
Q1 2019

May 15, 2019
SELL
$24.76 - $31.66 $153,908 - $196,798
-6,216 Reduced 1.22%
502,970 $13.8 Million
Q4 2018

Feb 14, 2019
SELL
$24.11 - $31.34 $3.74 Million - $4.86 Million
-155,000 Reduced 23.34%
509,186 $13.8 Million
Q3 2018

Nov 14, 2018
SELL
$26.99 - $35.85 $3.68 Million - $4.89 Million
-136,500 Reduced 17.05%
664,186 $19.4 Million
Q2 2018

Aug 14, 2018
BUY
$17.02 - $35.2 $3.55 Million - $7.34 Million
208,400 Added 35.19%
800,686 $25 Million
Q1 2018

May 15, 2018
SELL
$19.9 - $32.25 $3.04 Million - $4.93 Million
-152,849 Reduced 20.51%
592,286 $11.8 Million
Q4 2017

Feb 14, 2018
BUY
$22.0 - $30.51 $16.4 Million - $22.7 Million
745,135
745,135 $21.7 Million

Others Institutions Holding RYTM

# of Institutions
246
Shares Held
64M
Call Options Held
210K
Put Options Held
575K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $5.51B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email